Tvardi Therapeutics, Inc.
TVRD
$1.89
-$0.06-2.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.76% | 2.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.98% | -7.06% | |||
| Operating Income | 5.98% | 7.06% | |||
| Income Before Tax | 5.10% | 6.47% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.10% | 6.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.10% | 6.47% | |||
| EBIT | 5.98% | 7.06% | |||
| EBITDA | 5.99% | 7.09% | |||
| EPS Basic | 5.10% | 6.47% | |||
| Normalized Basic EPS | 5.10% | 6.48% | |||
| EPS Diluted | 4.87% | 6.47% | |||
| Normalized Diluted EPS | 5.10% | 6.48% | |||
| Average Basic Shares Outstanding | 0.00% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||